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Background and novelty
Product quality is a result of the entire production pro-
cess including protein sequence, cell substrate and pro-
cess parameters. Many of the desired product properties
are defined by posttranslational modifications with
impact on biological activity, immunogenicity, half-life
or stability. In-depth process understanding enables the
targeted modulation of product quality attributes by
rationally designed bioprocesses. This is valuable for
new biological molecules in order to improve efficacy,
reduce side effects, access new patient populations. For
biosimilars this allows developing into defined quality
attribute profiles. The identification of suitable process
parameters and media compositions to modulate quality
attributes is challenging due to the complexity of cell
culture processes.
Here, this challenge was approached by comprehensive
data analysis, in-depth characterization of charge variant
formation and high-throughput screening of process
parameters and media compounds.
Experimental approach
The impact of process parameters on product quality
attributes was analyzed with special focus on acidic
charge variants and glycosylation pattern. Initially a
database was created including process and analytical
data from twelve projects. Data sets of more than 2500
fed-batch processes with 6300 analytical data sets
enabled a cross-project analysis and correlation of pro-
cess parameters with product quality attributes.
The formation of charge variants was explored by uni-
and multivariate techniques within the database to iden-
tify potentially impacting process parameters. These
were then further investigated in experimental work.
Cell culture parameters impacting growth and product
formation rates like media osmolality and pH profiles
were tested in bioreactor cultivations. In addition,
post-harvest experiments exploring different pH, tem-
perature, light and buffer conditions were studied in sto-
rage stress studies. Data from both studies were
integrated to establish predictive modeling of charge var-
iant formation in upstream process supernatants.
In addition, the impact of cell culture conditions and
media compounds on the glycosylation pattern was
assessed by an integrated screening approach. Multi
parallel small scale bioreactors, robotics based product
capture and high throughput analytics were combined
to minimize hands-on-time to gain data for correlation
analysis.
Results and discussion
Said setups supported the identification of numerous
media supplements and upstream process conditions
that were applied for rational modulation of glycosyla-
tion patterns and charge variants. For the latter, the ana-
lysis of formation kinetics enabled modeling of charge
variant formation in process supernatants. A mechanis-
tic model was established based on first order degrada-
tion kinetics. Data from post-harvest experiments was
used to analyze dependencies of the molecule specific
degradation rate (qn) on pH and temperature (T). Here,
an exponential modulation by both process variables
was found. The degradation rate q is further modulated
by cell culture osmolality in a linear manner (compare
equation 1). With the resulting model the prediction of
final acidic molecule concentrations for five different
IgG molecules would be predicted with a RMSEP = 2.5 %
based the process variables product concentration, viable
cell density, pH, temperature, bioreactor volume and
osmolality in supernatants. The model clearly demon-
strated that the largest impact on the final abundance of
acidic molecule variants is product formation kinetics.
Constant protein synthesis supplies fresh monoclonal
antibody to the cell culture supernatant and thus dilutes
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the continuously formed acidic molecule variants. It was
shown that process formats that modulate growth rates
can especially facilitate this.
q = qn · 5.4 · 10−5 · e(0.109T + 0.811pH) · (2, 25− 0, 0035 ·Osmo) (1)
Moreover, a case study focusing on the optimization
of glycan patterns and antibody dependent cellular cyto-
toxicity by using metal ions as media supplements was
presented. Data provided by Gramer et al. (2011) clearly
indicated the linear correlation of manganese levels in
cell culture media with non-fucosylated N-glycan species
within a range from 0 to 40 µM. The described effect
could be demonstrated up to 500µM manganese result-
ing in a reduction of fucosylation from 95 % to 60 %in
15 mL scale fed-batch cultivations. In contrast, high
mannose type glycans were increased to only 15 %. By
this increase in the non-fucosylated glycan fraction,
CD16 binding affinity of the product molecule could be
increased up to 350 % (the linear correlation of CD16
binding affinity and defucosylated N-glycan levels is
described in literature, e.g. by Chung et al. (2012)) by
increased manganese concentrations in cell culture
media. Results obtained in 15 mL-scale were then veri-
fied in a 2 L-scale fed-batch processes. Cell lines expres-
sing a different recombinant IgG molecule were grown
in a cell culture medium containing 150 µM manganese.
As shown in Figure 1, this media tool successfully
enabled doubling the CD16 binding affinity of the mole-
cule caused by a reduction of fucosylation by 10%.
The overall derived database and toolbox is applied for
ongoing projects for fine tuning of product quality attri-
butes to meet desired characteristics. After gap analysis,
process parameters can be chosen for application in pro-
cess development to finally achieve high quality products.
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Figure 1 Impact of manganese concentration in cell culture media on fucosylation, mannosylation and CD16 binding affinity of
produced monoclonal antibodies. A linear dependency of CD16 binding affinity (empty circles) and fucosylation (filled triangles) with
manganese levels was characterized in 14-day fed-batch experiments in 15 mL-scale bioreactors (a). Mannosylation (filled diamonds) did not
correlate with manganese concentrations in a strictly linear manner. Results from the screening experiment were verified with a different cell line
in 2 L- scale (b). Final harvest titers (filled bars) were not impacted by manganese additions, while CD16 binding affinity of the product could be
doubled (striped bars) by reducing fucosylation levels (dotted bars) by 10 % with 150 µM manganese as media supplement. Error bars indicate
the standard deviation of biological duplicates.
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